Navigation Links
Thermage, Inc. to Present at the 2008 Thomas Weisel Partners Healthcare Conference
Date:8/27/2008

HAYWARD, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM), a leader in non-invasive tissue tightening in the aesthetic industry, announced today that it will present at the 2008 Thomas Weisel Partners Healthcare Conference at the Four Seasons Hotel in Boston. The Company's presentation is scheduled for Wednesday, September 3, 2008 at 4:25 p.m. Eastern Time. Stephen Fanning, Chairman, President and Chief Executive Officer of Thermage, will review the company's business strategy and historical financial results.

Attendance at the conference is by invitation only. Thermage will offer a live audio webcast of its presentation, which may be accessed at the Company's website at http://www.thermage.com. An archived replay of the presentation will be available following the live presentation for 30 days and will also be available at http://www.thermage.com.

About Thermage

Thermage's innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti-aging" market. For more information about Thermage, call 1-510-259-7117 or log on to http://www.thermage.com.


'/>"/>
SOURCE Thermage, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Thermage, Inc. to Present at the 10th Annual Needham & Company Growth Conference
2. Thermage, Inc. Announces Second Quarter 2008 Results Release Date and Conference Call
3. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
4. Avicena Group to Present at Noble Financial Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
8. CEL-SCI to Present at the Noble Financial Conference
9. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
10. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
11. Strategic Diagnostics Updates Roth Conference Presentation Time
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):MSU researcher unveils new approach to treat lower back pain 2H1N1 influenza adopted novel strategy to move from birds to humans 2H1N1 influenza adopted novel strategy to move from birds to humans 3H1N1 influenza adopted novel strategy to move from birds to humans 4Rodent smoke screen 2Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions 53882 1Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions 53882 2Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions 53882 3Ratcliff Adds Architect John Sealander to Healthcare Practice Group 13423 1Ratcliff Adds Architect John Sealander to Healthcare Practice Group 13423 2NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions 53879 1NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions 53879 2NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions 53879 3NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions 53879 4NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions 53879 5